IDEAYA Biosciences (IDYA) Current Assets (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Current Assets of $696.1 million for Q1 2026, up 4.41% sequentially from $666.7 million in Q4 2025, and down 1.66% YoY from $707.9 million in Q1 2025.
IDEAYA Biosciences (IDYA) Current Assets (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Current Assets for 9 years, with the latest figure at $696.1 million in Q1 2026.
- Quarterly Current Assets fell 1.66% year-over-year to $696.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696.1 million (down 1.66% YoY) and the FY2025 annual result came in at $666.7 million, down 3.33% from the prior year.
- Current Assets rose to $696.1 million in Q1 2026 per IDYA's latest filing, from $666.7 million in the prior quarter.
- Over five years, Current Assets peaked at $932.2 million in Q3 2024 and troughed at $256.0 million in Q1 2022.
- A 5-year average of $573.9 million and a median of $666.7 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2024: Current Assets declined 16.91% in 2022, then jumped 106.23% in 2024.
- Over 5 years, Current Assets stood at $370.5 million in 2022, then jumped by 43.78% to $532.6 million in 2023, then grew by 29.49% to $689.7 million in 2024, then slipped by 3.33% to $666.7 million in 2025, then grew by 4.41% to $696.1 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $696.1 million, $666.7 million, and $802.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | 864.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 864.03 Mn |
| Mar 31, 2026 | 696.11 Mn |
| Dec 31, 2025 | 666.73 Mn |
| Sep 30, 2025 | 802.66 Mn |
| Jun 30, 2025 | 685.60 Mn |
| Mar 31, 2025 | 707.87 Mn |
| Dec 31, 2024 | 689.71 Mn |
| Sep 30, 2024 | 932.21 Mn |
| Jun 30, 2024 | 713.18 Mn |
| Mar 31, 2024 | 709.35 Mn |
| Dec 31, 2023 | 532.63 Mn |
| Sep 30, 2023 | 482.18 Mn |
| Jun 30, 2023 | 501.79 Mn |
| Mar 31, 2023 | 343.96 Mn |
| Dec 31, 2022 | 370.45 Mn |
| Sep 30, 2022 | 393.44 Mn |
| Jun 30, 2022 | 272.19 Mn |
| Mar 31, 2022 | 256.05 Mn |
| Dec 31, 2021 | 251.00 Mn |
| Sep 30, 2021 | 268.96 Mn |